Curcumin enhances the immunosuppressive activity of cyclosporine in rat cardiac allografts and in mixed lymphocyte reactions.

[1]  J. Bright,et al.  Curcumin Inhibits Experimental Allergic Encephalomyelitis by Blocking IL-12 Signaling Through Janus Kinase-STAT Pathway in T Lymphocytes1 , 2002, The Journal of Immunology.

[2]  D. Shoskes.  Effect of bioflavonoids quercetin and curcumin on ischemic renal injury: a new class of renoprotective agents. , 1998, Transplantation.

[3]  T. Tan,et al.  Inhibition of the c-Jun N-terminal kinase (JNK) signaling pathway by curcumin , 1998, Oncogene.

[4]  L. Elliott,et al.  Curcumin blocks cyclosporine A-resistant CD28 costimulatory pathway of human T-cell proliferation. , 1998, The Journal of surgical research.

[5]  Jen-kun Lin,et al.  Induction of HSP70 gene expression by modulation of Ca+2 ion and cellular p53 protein by curcumin in colorectal carcinoma cells , 1996, Molecular carcinogenesis.

[6]  L. Rutzky,et al.  Challenges in Cyclosporine Therapy: The Role of Therapeutic Monitoring by Area Under the Curve Monitoring , 1995, Therapeutic drug monitoring.

[7]  C. Thompson,et al.  T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression , 1987, Molecular and cellular biology.

[8]  G. Wu,et al.  The effect of curcumin on human B-cell immortalization by Epstein-Barr virus. , 1998, The American surgeon.

[9]  N. Vermeulen,et al.  Cytotoxicity and cytoprotective activities of natural compounds. The case of curcumin. , 1996, Xenobiotica; the fate of foreign compounds in biological systems.

[10]  T. Chou,et al.  Synergism and antagonism in chemotherapy , 1991 .